Works matching IS 09395555 AND DT 2014 AND VI 93 AND IP 8


Results: 29
    1
    2
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.

    Published in:
    Annals of Hematology, 2014, v. 93, n. 8, p. 1413, doi. 10.1007/s00277-014-2053-9
    By:
    • Tatarelli, Caterina;
    • Piccioni, Anna;
    • Maurillo, Luca;
    • Naso, Virginia;
    • Battistini, Roberta;
    • D'Andrea, Mariella;
    • Criscuolo, Marianna;
    • Nobile, Carolina;
    • Villivà, Nicoletta;
    • Mancini, Stefano;
    • Neri, Benedetta;
    • Breccia, Massimo;
    • Fenu, Susanna;
    • Buccisano, Francesco;
    • Voso, Maria;
    • Latagliata, Roberto;
    • Aloe Spiriti, Maria
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial.

    Published in:
    Annals of Hematology, 2014, v. 93, n. 8, p. 1401, doi. 10.1007/s00277-014-2055-7
    By:
    • Aslanyan, Mariam;
    • Kroeze, Leonie;
    • Langemeijer, Saskia;
    • Koorenhof-Scheele, Theresia;
    • Massop, Marion;
    • Hoogen, Patricia;
    • Stevens-Linders, Ellen;
    • Locht, Louis;
    • Tönnissen, Evelyn;
    • Heijden, Adrian;
    • Silva-Coelho, Pedro;
    • Cilloni, Daniela;
    • Saglio, Giuseppe;
    • Marie, Jean-Pierre;
    • Tang, Ruoping;
    • Labar, Boris;
    • Amadori, Sergio;
    • Muus, Petra;
    • Willemze, Roel;
    • Marijt, Erik
    Publication type:
    Article
    21
    22
    23
    24
    25

    Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.

    Published in:
    Annals of Hematology, 2014, v. 93, n. 8, p. 1353, doi. 10.1007/s00277-014-2057-5
    By:
    • Oh, Sukjoong;
    • Koo, Dong;
    • Kwon, Min-Jung;
    • Kim, Kihyun;
    • Suh, Cheolwon;
    • Min, Chang-Ki;
    • Yoon, Sung-Soo;
    • Shin, Ho-Jin;
    • Jo, Deog-Yeon;
    • Kwak, Jae-Yong;
    • Kim, Jin;
    • Sohn, Sang;
    • Joo, Young-Don;
    • Eom, Hyeon-Seok;
    • Kim, Sung-Hyun;
    • Kim, Yang;
    • Kim, ChulSoo;
    • Mun, Yeung-Chul;
    • Kim, Hawk;
    • Lee, Dong
    Publication type:
    Article
    26

    Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma.

    Published in:
    Annals of Hematology, 2014, v. 93, n. 8, p. 1371, doi. 10.1007/s00277-014-2063-7
    By:
    • Huang, Shang-Yi;
    • Lin, Chung-Wu;
    • Lin, Hsiu-Hsia;
    • Yao, Ming;
    • Tang, Jih-Luh;
    • Wu, Shang-Ju;
    • Chen, Yao-Chang;
    • Lu, Hsiao-Yun;
    • Hou, Hsin-An;
    • Chen, Chien-Yuan;
    • Chou, Wen-Chien;
    • Tsay, Woei;
    • Chou, Sheng-Je;
    • Tien, Hwei-Fang
    Publication type:
    Article
    27
    28
    29